We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First-Ever Breast Cancer AI for Mammography Scans Shows How It Comes To Conclusions

By MedImaging International staff writers
Posted on 27 Jan 2022
Print article
Illustration
Illustration

A new artificial intelligence (AI) tool for mammography scans aims to aid rather than replace human decision-making.

Computer engineers and radiologists at Duke University (Durham, NC, USA) have developed an AI platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, this algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.

The researchers trained the AI to locate and evaluate lesions just like an actual radiologist would be trained, rather than allowing it to freely develop its own procedures, giving it several advantages over its “black box” counterparts. It could make for a useful training platform to teach students how to read mammography images. It could also help physicians in sparsely populated regions around the world who do not regularly read mammography scans make better health care decisions.

The researchers trained the new AI with 1,136 images taken from 484 patients at Duke University Health System. They first taught the AI to find the suspicious lesions in question and ignore all of the healthy tissue and other irrelevant data. Then they hired radiologists to carefully label the images to teach the AI to focus on the edges of the lesions, where the potential tumors meet healthy surrounding tissue, and compare those edges to edges in images with known cancerous and benign outcomes. Radiating lines or fuzzy edges, known medically as mass margins, are the best predictor of cancerous breast tumors and the first thing that radiologists look for. This is because cancerous cells replicate and expand so fast that not all of a developing tumor’s edges are easy to see in mammograms.

After training was complete, the researches put the AI to the test. While it did not outperform human radiologists, it did just as well as other black box computer models. When the new AI is wrong, people working with it will be able to recognize that it is wrong and why it made the mistake. Moving forward, the team is working to add other physical characteristics for the AI to consider when making its decisions, such as a lesion’s shape, which is a second feature radiologists learn to look at.

“This is a unique way to train an AI how to look at medical imagery,” said Alina Barnett, a computer science PhD candidate at Duke and first author of the study. “Other AIs are not trying to imitate radiologists; they’re coming up with their own methods for answering the question that are often not helpful or, in some cases, depend on flawed reasoning processes.”

Related Links:
Duke University

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Under Table Shield
3 Section Double Pivot Under Table Shield
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Ultrasound Table
Ergonomic Advantage (EA) Line

Print article
Radcal

Channels

MRI

view channel
Image: Exablate Prime features an enhanced user interface and enhancements to optimize productivity (Photo courtesy of Insightec)

Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery

Essential tremor, often called familial, idiopathic, or benign tremor, leads to uncontrollable shaking that significantly affects a person’s life. When traditional medications do not alleviate symptoms,... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.